TY - JOUR T1 - Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1495 LP - 1503 DO - 10.2967/jnumed.120.261016 VL - 62 IS - 11 AU - Valery Radchenko AU - Alfred Morgenstern AU - Amir R. Jalilian AU - Caterina F. Ramogida AU - Cathy Cutler AU - Charlotte Duchemin AU - Cornelia Hoehr AU - Ferrid Haddad AU - Frank Bruchertseifer AU - Haavar Gausemel AU - Hua Yang AU - Joao Alberto Osso AU - Kohshin Washiyama AU - Kenneth Czerwinski AU - Kirsten Leufgen AU - Marek Pruszyński AU - Olga Valzdorf AU - Patrick Causey AU - Paul Schaffer AU - Randy Perron AU - Samsonov Maxim AU - D. Scott Wilbur AU - Thierry Stora AU - Yawen Li Y1 - 2021/11/01 UR - http://jnm.snmjournals.org/content/62/11/1495.abstract N2 - Encouraging results from targeted α-therapy have received significant attention from academia and industry. However, the limited availability of suitable radionuclides has hampered widespread translation and application. In the present review, we discuss the most promising candidates for clinical application and the state of the art of their production and supply. In this review, along with 2 forthcoming reviews on chelation and clinical application of α-emitting radionuclides, The Journal of Nuclear Medicine will provide a comprehensive assessment of the field. ER -